SCHEMBL24314993

SCHEMBL24314993

COc1cccc(-c2ccc3c(c2)CCC(=O)N3)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.70
CYP11B1 P15538 3/20 0.70
CYP11B2 P19099 3/20 0.70
PKM P14618 2/20 0.59
CYP2C9 P11712 1/20 0.58
TBXAS1 P24557 1/20 0.58
PDE3B Q13370 1/20 0.58
PDE3A Q14432 1/20 0.58
KIF11 P52732 2/20 0.55
PGR P06401 3/20 0.54
CRBN Q96SW2 2/20 0.54
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
CHEK1 O14757 1/20 0.50
KCNH2 Q12809 1/20 0.49
ALDH1A1 P00352 2/20 0.49
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48
MMP12 P39900 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314020 0.84 CYP11B1 (0.55) CYP1A2CYP11B1CYP11B2PKMCYP2C9
SCHEMBL1764375 0.84 PKM (0.65) CYP1A2CYP11B1CYP11B2PKMCYP2C9
SCHEMBL29546603 0.83 PGR (0.54) CYP1A2CYP11B1CYP11B2PDE3BPDE3A
SCHEMBL1119377 0.83 CYP11B1 (1.00) CYP1A2CYP11B1CYP11B2PKMCYP2C9
SCHEMBL3468129 0.83 KIF11 (0.69) CYP1A2CYP11B1CYP11B2CYP2C9TBXAS1
SCHEMBL24314052 0.81 CYP11B1 (0.52) CYP1A2CYP11B1CYP11B2PKMCYP2C9
SCHEMBL13525229 0.81 CYP11B1 (0.62) CYP1A2CYP11B1CYP11B2PKMCYP2C9
SCHEMBL3306566 0.81 KIF11 (0.69) CYP1A2CYP11B1CYP11B2CYP2C9TBXAS1
SCHEMBL16208517 0.80 KIF11 (0.72) CYP1A2CYP11B1CYP11B2PKMKIF11
SCHEMBL4406856 0.79 CRBN (0.57) PDE3BPDE3APGRCRBNCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076820-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-14 WO disclosed